Homealder

  • New Ph 3 Efficacy data presented for Eptinezumab in Episodic and Chronic Migraine

    • July 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Alder to present new data for Eptinezumab at American Headache Society Meeting

    • June 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Alder appoints new CEO to better prepare for Migraine drug launch

    • June 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New data demonstrates Eptinezumab Increased Migraine-Free Intervals and improved Quality-of-Life Outcomes in Episodic Migraine patients

    • April 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Alder to present Phase 3 Eptinezumab results at AAN 2018

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more